The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stormal cultures from the effects of mafosfamide (Asta Z 7654)

Experimental Hematology

Volumn 24, Issue 1, 1996, Pages 77-81

  Genevay, M C ^a   Mormont, C ^a   Thomas, F ^a   Berthier, R ^a  

^a Laboratoires Hemeris   (France)

Author keywords

AcsDKP; CD34+ cells; Long term bone marrow culture; Mafosfamide

Indexed keywords

ANTIDOTE; CD34 ANTIGEN; MAFOSFAMIDE; MAFOSFAMIDE LYSINE; SERASPENIDE;

ARTICLE; BONE MARROW CULTURE; COLONY FORMING UNIT GM; CONTROLLED STUDY; GROWTH STIMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; STROMA;

AMINO ACID SEQUENCE; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BONE MARROW; BONE MARROW CELLS; CELLS, CULTURED; CYCLOPHOSPHAMIDE; ERYTHROID PROGENITOR CELLS; GRANULOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGES; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; STROMAL CELLS;

EID: 0030035025     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)